Table 4.
CIMP status | Stages I-II (n = 149) | Stages III-IV (n = 129) | ||||||
---|---|---|---|---|---|---|---|---|
Univariate | Multivariate§ | Univariate | Multivariate§ | |||||
HR and 95% CI | P | HR and 95% CI | P | HR and 95% CI | P | HR and 95% CI | P | |
CIMP-H versus CIMP-L/0 | 0.69 (0.17–2.91) | 0.62 | 0.52 (0.12–2.22) | 0.38 | 1.81 (1.02–3.24) | 0.04 | 1.75 (0.95–3.23) | 0.07 |
CIMP-H versus CIMP-L | 0.74 (0.17–3.14) | 0.68 | 0.57 (0.13–2.48) | 0.46 | 1.73 (0.96–3.11) | 0.07 | 1.50 (0.80–2.81) | 0.20 |
CIMP-L versus CIMP-0 | 0.66 (0.27–1.60) | 0.35 | 0.57 (0.23–1.41) | 0.22 | 1.42 (0.60–3.34) | 0.43 | 2.06 (0.77–5.53) | 0.15 |
CIMP-H versus CIMP-0 | 0.71 (0.32–1.58) | 0.40 | 0.56 (0.21–1.49) | 0.24 | 1.55 (0.96–2.49) | 0.07 | 1.67 (1.00–2.81) | 0.05 |
§Multivariate analysis, adjusted for age at diagnosis, tumor stage, tumor differentiation, and tumor location.